Company intelligence / Profile preview

Corsens Medical

Ownership: Private
Development stage: Commercial

Overview

Corsens Medical has developed and clinically validated a wearable device that uses chest wall micro-vibration analysis to rapidly distinguish cardiac from non-cardiac chest pain. The system integrates real-time data transmission and cloud-based AI algorithms for rapid diagnosis, aiming to reduce unnecessary ER visits and improve early heart attack detection. The company has filed for FDA 510(k) clearance but is not yet commercialized[3][4].

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapyDigital health solution (wearable sensor + AI algorithm)
Industry: Physiological Monitoring

Partnerships

Telemedicine platforms in Israel such as Shahal and Natali are mentioned as integration partners for remote diagnosis delivery[3].

Beyond the preview

Go deeper on Corsens Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corsens Medical.

Explore the full profile